Early detection and monitoring of neurodegenerative and neurodevelopmental disorders, healthy aging
Targeted approach: brain-enriched microRNA biomarkers in plasma
Collaborations with academia, medical centers, disease foundations and industry
Peer-reviewed publications, grant awards, patents
At DiamiR, we focus on the development and commercialization of an innovative technology based on analysis of brain-enriched microRNA biomarkers in blood plasma to be used for screening, early and differential diagnosis, enrollment of better defined participants into clinical trials, as well as disease progression and treatment monitoring.